Search - tctmd.com

Displaying 781 - 800 of 1258

Sort: Relevancy | Date

News Daily News

Trials of New Cancer Drugs Failing to Address Potential CV Risks

Todd Neale

February 10, 2020

News Daily News

Patient-Level Data Strengthen Rosiglitazone-CV Link: Meta-analysis

Caitlin E. Cox

February 07, 2020

News Daily News

SYNTAX Score Predicts Long-term Benefits of Left Main PCI and CABG: MAIN-COMPARE

Michael O'Riordan

February 03, 2020

News Conference News LINC 2020

Common-Femoral Lesions: LINC 2020 Experts Hash Out the Best PAD Treatment

L.A. McKeown

January 31, 2020

News Conference News LINC 2020

Lutonix BTK Studies: Below-the-Knee Challenges Linger

L.A. McKeown

January 29, 2020

News Conference News STS 2020

TAVR Tussle at US Surgery Meeting Threatens to Widen Surgeon-Cardiologist Wedge

Yael L. Maxwell

January 29, 2020

News Daily News

Earlier, Longer Interventions Proposed for Optimal Population LDL Cholesterol

Yael L. Maxwell

January 28, 2020

News Conference News ISET 2020

FDA’s First Take on New Paclitaxel Concerns in CLI

Caitlin E. Cox

January 24, 2020

News Conference News ISET 2020

PAD Care on the Backdrop of Cancer Requires Creativity, Persistence

Caitlin E. Cox

January 23, 2020

News Daily News

Most Clinical Trial Sponsors Fail to Report Data as Mandated by FDA

Michael O'Riordan

January 21, 2020

News Daily News

Clopidogrel Interaction With Morphine in ACS Linked to More Ischemic Events

Shelley Wood

January 20, 2020

News Daily News

Paclitaxel DCBs Now Implicated in Death, Amputation in Below-the-Knee CLI

L.A. McKeown

January 15, 2020

News Daily News

Lp(a) Reduction Contributes to Alirocumab’s Treatment Benefit: ODYSSEY Outcomes

Michael O'Riordan

January 14, 2020

News Features

The Cancer Patient Needing PCI Poses Conundrums for Care

Shelley Wood

January 14, 2020

News Daily News

Community Death Rates Following Type 2 MI Speak to Lack of Treatments, Trials

Yael L. Maxwell

January 10, 2020

News Features

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

Michael O'Riordan

January 10, 2020

News Daily News

EACTS Offers to Help to Resolve EXCEL Controversy, as CRF Launches Review

Michael O'Riordan

January 08, 2020

News Daily News

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

Michael O'Riordan

January 03, 2020

News Opinion Editor's Corner

The Biggest News of 2019: TCTMD’s Top 10

Shelley Wood

January 01, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2019

Shelley Wood

December 31, 2019

Advertisement

Trials of New Cancer Drugs Failing to Address Potential CV Risks

Patient-Level Data Strengthen Rosiglitazone-CV Link: Meta-analysis

SYNTAX Score Predicts Long-term Benefits of Left Main PCI and CABG: MAIN-COMPARE

Common-Femoral Lesions: LINC 2020 Experts Hash Out the Best PAD Treatment

Lutonix BTK Studies: Below-the-Knee Challenges Linger

TAVR Tussle at US Surgery Meeting Threatens to Widen Surgeon-Cardiologist Wedge

Earlier, Longer Interventions Proposed for Optimal Population LDL Cholesterol

FDA’s First Take on New Paclitaxel Concerns in CLI

PAD Care on the Backdrop of Cancer Requires Creativity, Persistence

Most Clinical Trial Sponsors Fail to Report Data as Mandated by FDA

Clopidogrel Interaction With Morphine in ACS Linked to More Ischemic Events

Paclitaxel DCBs Now Implicated in Death, Amputation in Below-the-Knee CLI

Lp(a) Reduction Contributes to Alirocumab’s Treatment Benefit: ODYSSEY Outcomes

The Cancer Patient Needing PCI Poses Conundrums for Care

Community Death Rates Following Type 2 MI Speak to Lack of Treatments, Trials

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

EACTS Offers to Help to Resolve EXCEL Controversy, as CRF Launches Review

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

The Biggest News of 2019: TCTMD’s Top 10

TCTMD’s Top 10 Most Popular Stories for December 2019

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content